WASS ROMANA
- former member of the university
Publications
16 Publications
2022
Journal Articles
Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity.
Wass, R; Hochmair, M; Kaiser, B; Grambozov, B; Feurstein, P; Weiss, G; Moosbrugger, R; Sedlmayer, F; Lamprecht, B; Studnicka, M; Zehentmayr, F
CANCERS. 2022; 14(13):
Full papers/articles (Journal)
2021
Journal Articles
Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis.
Grambozov, B; Nussdorfer, E; Kaiser, J; Gerum, S; Fastner, G; Stana, M; Gaisberger, C; Wass, R; Studnicka, M; Sedlmayer, F; Zehentmayr, F;
Curr Oncol. 2021; 28(3):1835-1846
Full papers/articles (Journal)
Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single-center retrospective analysis.
Grambozov, B; Wass, R; Stana, M; Gerum, S; Karner, J; Fastner, G; Studnicka, M; Sedlmayer, F; Zehentmayr, F
THORAC CANCER. 2021; 12(8): 1162-1170.
Full papers/articles (Journal)
Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy-A Retrospective Bi-Centric Cohort Study.
Lang, D; Brauner, A; Huemer, F; Rinnerthaler, G; Horner, A; Wass, R; Brehm, E; Kaiser, B; Greil, R; Lamprecht, B;
Cancers (Basel). 2021; 14(1):
Full papers/articles (Journal)
Checkpoint inhibitor pneumonitis: Short review of literature and case report
Wass, RE; Lang, D; Horner, A; Lamprecht, B
MEMO-MAG EUR MED ONC. 2021;
Reviews
2020
Journal Articles
Pulmonary function decreases moderately after accelerated high-dose irradiation for stage III non-small cell lung cancer.
Grambozov, B; Wolf, F; Kaiser, J; Wass, R; Fastner, G; Gaisberger, C; Rettenbacher, L; Studnicka, M; Pirich, C; Sedlmayer, F; Zehentmayr, F;
Thorac Cancer. 2020; 11(2):369-378
Full papers/articles (Journal)
Later-Line Treatment with Lorlatinib in
Hochmair, MJ; Fabikan, H; Illini, O; Weinlinger, C; Setinek, U; Krenbek, D; Prosch, H; Rauter, M; Schumacher, M; Woll, E; Wass, R; Brehm, E; Absenger, G; Bundalo, T; Errhalt, P; Urban, M; Valipour, A
PHARMACEUTICALS-BASE. 2020; 13(11):
Full papers/articles (Journal)
[Masterplan 2025 of the Austrian Society of Pneumology (ASP)-the expected burden and management of respiratory diseases in Austria].
Studnicka, M; Baumgartner, B; Bolitschek, J; Doberer, D; Eber, E; Eckmayr, J; Hartl, S; Hesse, P; Jaksch, P; Kink, E; Kneussl, M; Lamprecht, B; Olschewski, H; Pfleger, A; Pohl, W; Prior, C; Puelacher, C; Renner, A; Steflitsch, W; Stelzmuller, I; Taubl, H; Vonbank, K; Wagner, M; Wantke, F; Wass, R
WIEN KLIN WOCHENSCHR. 2020; 132(Suppl 3): 89-113.
Full papers/articles (Journal)
Conference papers, proceedings, abstracts
Later-line treatment with lorlatinib in ALK-and ROS1-rearrangement-positive NSCLC: a retrospective, multicenter analysis
Illini, O; Hochmair, MJ; Fabikan, H; Weinlinger, C; Setinek, U; Krenbek, D; Prosch, H; Rauter, M; Schumacher, M; Woll, E; Wass, R; Brehm, E; Absenger, G; Bundalo, T; Errhalt, P; Urban, M; Valipour, A
WIEN KLIN WOCHENSCHR. 2020; 132(19-20): 610-610.
Abstracts (Journal)
2019
Journal Articles
Survival in early lung cancer patients treated with high dose radiotherapy is independent of pathological confirmation.
Zehentmayr, F; Sprenger, M; Rettenbacher, L; Wass, R; Porsch, P; Fastner, G; Pirich, C; Studnicka, M; Sedlmayer, F;
Thorac Cancer. 2019; 10(2):321-329
Full papers/articles (Journal)
2018
Conference papers, proceedings, abstracts
ROS-1, Robotic Surgery and renal Lesions in a Patient with metastatic Adenocarcinoma of the Lung
Rehman, A; Wass, R; Jordan, F; Rudelstorfer, G; Porsch, P; Hutter, J; Mitterberger, M; Hutarew, G; Sotlar, K; Studnicka, M
WIEN KLIN WOCHENSCHR. 2018; 130(19-20): 598-598.
Abstracts (Journal)
2017
Journal Articles
Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study.
Weiss, G; Steinacher, I; Lamprecht, B; Kaiser, B; Mikes, R; Sator, L; Hartl, S; Wagner, H; Studnicka, M
NPJ PRIM CARE RESP M. 2017; 27(1): 4
Full papers/articles (Journal)
2016
Conference papers, proceedings, abstracts
EGFR T790M resistance mutation in NSCLC: Real-life data of Austrian patients treated with osimertinib
Holzer, S; Hochmair, M; Filipits, M; Mohn-Staudner, A; Errhalt, P; Absenger, G; Bundalo, T; Arns, BM; Setinek, U; Mikes, R; Kolb, R; Schumacher, M; Zochbauer-Muller, S; Patocka, K; Haslbauer, F; Rudzki, J; Burghuber, OC
WIEN KLIN WOCHENSCHR. 2016; 128(19-20): 769-770.
Abstracts (Journal)
2015
Journal Articles
First line crizotinib in anaplastic lymphoma kinase (ALK) rearranged squamous cell lung cancer.
Mikes, RE; Jordan, F; Hutarew, G; Studnicka, M;
Lung Cancer. 2015; 90(3): 614-616.
Case Reports
Conference papers, proceedings, abstracts
The Austrian Severe Asthma Registry
Doberer, D; Auer, W; Loffler-Ragg, J; Kahler, C; Moritz, K; Kneussl, M; Messner, J; Lins, F; Cerkl, P; Kaufmann, E; Flicker, M; Klade, S; Lamprecht, B; Rowhani, M; Mikes, R; Studnicka, M; Zacharasiewicz, A; Marth, K; Pohl, W; Lang, B; Eckmayr, J; Wantke, F
WIEN KLIN WOCHENSCHR. 2015; 127(19-20): 821-822.
Abstracts (Journal)
2011
Conference papers, proceedings, abstracts
Pulmonary infection with M. szulgai - case report of a rare pathogen
Mikes, R; Kern, JM; Maass, V; Hartl, R; Maass, M; Studnicka, M
WIEN KLIN WOCHENSCHR. 2011; 123(17-18): A8-A9.
Abstracts (Journal)